About The Rx Consultant

The Rx Consultant is a subscription-based service that delivers practical updates & reviews covering all the top-selling drugs and common health conditions. Our publications focus on the facts busy front-line pharmacists and other health care practitioners need to stay current, and provide it a streamlined, easy reading style.

Founded in 1991, The Rx Consultant has subscribers throughout the United States, Canada & The United Kingdom. For 27 years, pharmacists, nurse practitioners and pharmacy technicians have relied on The Rx Consultant for accurate, unbiased updates they can trust. We are completely independent of the pharmaceutical industry and has no commercial bias.

→ Visit The Rx Consultant

Rx Blog users - Save 40% on a subscription to
The Rx Consultant

Use Promo Code RXBLOG18

→ Subscribe Now

1-800-798-3353 rxmail@rxconsultant.com

There are 5 newer blood thinning medications on
the market for the treatment and/or prevention of blood
clots, and for the prevention of stroke in patients with
atrial fibrillation (A-fib). They are known as DOACs.

In general, DOACs work as well or better
than warfarin and may be safer; however, each blood
thinner has its own advantages and disadvantages. Your
health care provider will choose the best medication
for you based on many things, including your specific
medical problem, how well your kidneys work, your
age, and your weight. The DOACs do not require blood
tests as often as warfarin does. However, regular exams
and blood tests to check your kidney function are needed
while taking a DOAC. The DOACs are not yet available
as generic medications and are usually more expensive
than Coumadin® (warfarin). You can discuss the costs
with your provider.

Share This